The chemotaxis machinery of Bacillus subtilis is similar to that of the well characterized system of Escherichia coli. However, B. subtilis contains several chemotaxis genes not found in the E. coli genome, such as cheC and cheD, indicating that the B. subtilis chemotactic system is more complex. In B. subtilis, CheD is required for chemotaxis; the cheD mutant displays a tumbly phenotype, has abnormally methylated chemoreceptors, and responds poorly to most chemical stimuli. Chemotactic prokaryotes respond behaviorally to chemoeffectors by altering the flux of phosphoryl groups through the two-component system composed of the histidine kinase CheA and its cognate response regulator CheY (1, 2). In Escherichia coli, transmembrane chemoreceptors are coupled by CheW to the CheA kinase to elevate phosphoryl group flux through the system during the excitation response to repellent stimuli (3-5). Adaptation to repellent stimuli depends on dephosphorylation of CheY-P, enhanced by oligomeric CheZ (3, 6, 7). The chemoreceptors are covalently modified by methylesterification of Glu side chains (8). Modulation of the net methylation level of the receptors provides a simple chemical "memory," allowing responses to continuously changing concentration gradients (9). Receptor methylation levels are dynamically controlled through the action of two modification enzymes, a methyltransferase, CheR, and a methylesterase, CheB. CheR methylesterifies specific Glu side chains on receptors using S-adenosylmethionine as a methyl donor (8); CheB catalyzes the hydrolysis of these glutamyl methyl esters, releasing methanol and regenerating a Glu (10). CheR and CheB are the only known chemoreceptor modification enzymes.
Chemotactic prokaryotes respond behaviorally to chemoeffectors by altering the flux of phosphoryl groups through the two-component system composed of the histidine kinase CheA and its cognate response regulator CheY (1, 2) . In Escherichia coli, transmembrane chemoreceptors are coupled by CheW to the CheA kinase to elevate phosphoryl group flux through the system during the excitation response to repellent stimuli (3) (4) (5) . Adaptation to repellent stimuli depends on dephosphorylation of CheY-P, enhanced by oligomeric CheZ (3, 6, 7) . The chemoreceptors are covalently modified by methylesterification of Glu side chains (8) . Modulation of the net methylation level of the receptors provides a simple chemical "memory," allowing responses to continuously changing concentration gradients (9) . Receptor methylation levels are dynamically controlled through the action of two modification enzymes, a methyltransferase, CheR, and a methylesterase, CheB. CheR methylesterifies specific Glu side chains on receptors using S-adenosylmethionine as a methyl donor (8) ; CheB catalyzes the hydrolysis of these glutamyl methyl esters, releasing methanol and regenerating a Glu (10) . CheR and CheB are the only known chemoreceptor modification enzymes.
Chemoreceptor modification occurs at specific, cytoplasmic Glu residues located within a well defined consensus sequence originally determined using methylated receptors derived from E. coli (11, 12) . This consensus sequence has been successfully used to identify methylation sites on receptors of the distantly related organism Bacillus subtilis (13, 14) . The consensus exhibits some slight variability; receptors are often, but not exclusively, synthesized with Glu at the site of modification. In some instances, the modified site is encoded as Gln rather than Glu in the corresponding receptor gene. When this situation occurs on an E. coli receptor, the CheB methylesterase first acts as a deamidase; amide hydrolysis of Gln residues produces Glu at the corresponding position in the mature protein. These Glu residues are then subject to cycles of reversible methylation (15) . Because the B. subtilis methylesterase complemented an E. coli cheB strain in swarm assays (16) , it has been assumed that the B. subtilis methylesterase possesses an equivalent glutaminase activity.
Modification (methylation, demethylation, or deamidation) of the E. coli chemoreceptors has substantial effects on the electrophoretic mobility of the molecules during SDS-PAGE. Incorporation of methyl groups via CheR causes the receptor to migrate more rapidly through the acrylamide matrix (or at a lower apparent M r ), whereas demethylation or deamidation via CheB causes the receptor to migrate more slowly through the acrylamide matrix (or at a higher apparent M r ) (15, (17) (18) (19) (20) .
B. subtilis utilizes a similar complement of proteins for chemotaxis, including homologs of the transmembrane chemoreceptors, CheW coupler, CheA kinase, CheY regulator, and CheR/CheB receptor-modification enzymes (21, 22) . However, chemotaxis by B. subtilis deviates from the E. coli paradigm in many ways. For example, B. subtilis lacks a homolog of the CheZ phosphatase present in E. coli and other closely related ␥-proteobacteria. Moreover, B. subtilis possesses several chemotaxis genes that have no counterparts in E. coli, including cheC, cheD, and cheV. The roles of CheC, CheD, and CheV in B. subtilis chemotaxis have not been well characterized. Recent work suggests roles for CheV and CheC during adaptation to chemotactic stimuli (21, 23) , although their mechanism of action remains elusive; less is known about the function of CheD. cheD mutant cells exhibit poorly methylated receptors, clockwise flagellar rotational bias (cells are tumbly), and decreased sensitivity to attractants (21, 24) . Additionally, a recent report noted the unexpected observation that one B. subtilis chemoreceptor, McpA, appeared to be absent in a cheD mutant (21) . No link connecting these disparate phenotypes has been established. The apparent nonspecific nature of the chemotactic defects of the cheD mutant has precluded assignment of a specific biochemical function to CheD. Furthermore, its func-tion cannot be inferred from sequence comparisons because all CheD homologs in the publicly available data base are putative proteins for which no function has been described. Although CheD function has remained a mystery, the discovery of CheD homologs within chemotaxis-like operons of a large number of bacterial and archaeal species (21) suggests that CheD plays an important role in chemoreceptor-mediated sensory transduction for many organisms.
This report presents the first evidence identifying a specific molecular function for the CheD protein. We demonstrate that B. subtilis CheD catalyzes amide hydrolysis of specific glutaminyl side chains of the B. subtilis chemoreceptor McpA. CheD can thus be classified as a chemoreceptor glutamine deamidase (E.C. 3.5.1.44). Because the cheD mutant exhibits a considerable clockwise prestimulus flagellar rotational bias (similar to a B. subtilis CheA null mutant) and cheD cells do not respond to most chemoattractants, we conclude that CheD-mediated receptor deamidation is required for productive communication of the conformational signals of the receptors to the CheA kinase.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Growth Media-Bacterial strains and plasmids used in this study are listed in Table I . DNA manipulations were performed according to standard protocols. Plasmids pAIN750mcpA and pAIN750mcpC were constructed by first amplifying the corresponding mcp gene and its promoter from B. subtilis chromosomal DNA via PCR using Pfu polymerase (Stratagene). The amplification products were cloned into pAIN750 using primer-encoded EcoRI and BamHI restriction sites for mcpA or EcoRI and NotI restriction sites for mcpC. Site-specific mutations in mcpA were created as described (13) using pAIN750mcpA as template. For use in an independent line of investigation, both pAIN750mcpA and pAIN750mcpC had a BglII restriction site incorporated into the region coding for the receptor c-terminal domain using a previously described method (13) . These nucleotide sequence alterations were phenotypically "silent"; that is, they did not result in any change of the amino acid sequence of the receptors.
A plasmid (pAIN620) designed to express a His 6 -tagged McpA cytoplasmic fragment (c-fragment) 1 was constructed by amplifying the Cterminal domain of McpA from pAIN750mcpA using Pfu polymerase and cloning the amplification product into the BamHI site of pUSH1 to create pAIN620. The amplification primers encoded BamHI sites and were designed to generate an in-frame N-terminal His-tagged fusion of the entire McpA cytoplasmic sequence beginning with McpA Arg-303. A second plasmid designed to co-express cheD with the c-fragment (pAIN153) was constructed via a multistep process as follows. Because the wild-type ribosome binding site (RBS) for cheD is a poor match for the B. subtilis consensus RBS (25) , resulting in low expression levels, site-specific mutations were introduced into pWN5 as described (13) to create a consensus RBS upstream of the cheD coding sequence (pAIN150). This procedure concomitantly introduced an adjacent HindIII site. The 0.8-kb HindIII/EcoRI fragment of pAIN150 containing cheD, and its RBS was subcloned into the HindIII/EcoRI sites of pSK, generating pAIN151. A 1.2-kb EcoRI/NotI fragment of pAIN620 containing the gene for the c-fragment, and its RBS was subcloned into the EcoRI/NotI sites of pAIN151, generating pAIN152. Finally, a 2.1-kb SalI fragment of pAIN152 containing cheD and the c-fragment was :cat alleles in combination with the 10 mcp mutations were constructed as described for OI3545 (26) using OI2934 (cheD) or OI2836 (cheB) as host strains. The cheR3::cat allele was introduced into relevant strains via PBS1 co-transduction with the nearby trpF ϩ marker. Chemoreceptors were expressed in B. subtilis strains by integration into the amyE locus as described (13) . LB is 1% tryptone, 0.5% yeast extract, 0.5% NaCl.
Immunoblot Analysis-Bacteria were diluted 1:100 into LB from saturated overnight cultures and incubated at 37°C with agitation (250 rpm) until they reached early stationary phase. Cells were pelleted, resuspended in protoplast buffer (20% sucrose, 25 mM potassium phosphate, 10 mM MgCl 2 , 30 mM sodium lactate, 1 mM EDTA, pH 7 (27)) plus 5 mg/ml lysozyme at A 600 of 1.0, and incubated at 37°C as before for 35 m. 1-ml protoplast samples were pelleted and resuspended in 0.1 ml of 4ϫ SDS sample-loading buffer (28) . Electrophoresis and electroblotting were performed as described (21) (21).
Protein Purification and in Vitro Reactions-C-fragments were purified under denaturing conditions using nickel-nitrilotriacetic acid agarose (Qiagen), essentially according to the manufacturer's instructions. A 1-liter culture of LB plus antibiotic (10 g/ml chloramphenicol or 100 g/ml ampicillin) was inoculated 1:100 with an overnight culture of RP3098 harboring pAIN620 (for the unmodified c-fragment) or pAIN153 (for the CheD-modified c-fragment) and grown at 37°C with agitation (250 rpm) to an A 600 of 0.8. IPTG was added to 1 mM; incubation was continued as before, and cells were harvested by centrifugation (5000 ϫ g, 5 min) after 3 h. Cell pellets were frozen at Ϫ70°C. Thawed cell pellets were resuspended in Buffer B (8 M urea, 0.1 M NaH 2 PO 4 , 0.01 M Tris, pH 8) and incubated at room temperature for 1 h with mixing. The supernatants were clarified by two serial centrifugations (5000 ϫ g, 5 min; 20,000 ϫ g, 40 min) and incubated with nickel-nitrilotriacetic acid agarose resin (pre-equilibrated in Buffer B) at room temperature for 1 h with mixing. The resin was batch-washed twice with Buffer B and twice with Buffer C (Buffer B with pH adjusted to 6.3) and then applied to a gravity flow column and washed with 10 column volumes of Buffer C. Elution was performed in 20 ml of Buffer E (Buffer B with pH adjusted to 4.5). The eluates were concentrated to ϳ1 ml using a cellulose ultrafiltration membrane (Millipore) in an Amicon ultrafiltration cell. These samples were dialyzed against three changes of 25 mM NH 4 HCO 3 at 4°C, and aliquots were frozen at Ϫ70°C.
For purification of glutathione S-transferase-CheD fusion protein (GST-CheD), a saturated overnight culture of pGXOB was diluted 1:100 into 1 liter of LB plus 100 g/ml ampicillin and grown at 37°C (250 rpm) to A 600 of 0.8. IPTG was added to 1 mM, and the culture was incubated (200 rpm) overnight at room temperature. Cells were pelleted and frozen as above. Thawed cell pellets were resuspended in phosphate-buffered saline (150 mM NaCl, 16 mM Na 2 HPO 4 , 4 mM NaH 2 PO 4 , pH 7.3) and disrupted by sonication. The supernatant was clarified as above and applied to a 2-ml gravity flow glutathione-Sepharose 4B column (Amersham Biosciences). The column was washed with 15 column volumes of phosphate-buffered saline, and elution was performed using 10 ml of elution buffer (50 mM Tris, 5 mM glutathione, pH 8). The eluate was concentrated as above. The sample was dialyzed against three changes of 50 mM Tris (pH 8), 10% glycerol at 4°C, and aliquots were frozen at Ϫ70°C.
For in vitro reactions, 1 M c-fragment was incubated with the indicated amounts of GST-CheD at room temperature in reaction buffer (50 mM Tris, pH 7.5, 0.1 mM dithiothreitol, 1 mM MgCl 2 , 0.5 mM EDTA). At the indicated times, samples (10 l) were removed and mixed with 10 l of 2ϫ SDS loading buffer. Immunoblotting was performed as described above.
Protein Analysis-CNBr digestion was performed essentially as described (29) . Aliquots of purified c-fragments (0.5-1 nmol) were dried under vacuum using a SpeedVac and resuspended in 0.1 M HCl. A small, unweighed crystal of CNBr was added; the reaction was vortexed to dissolve the crystal and incubated overnight at room temperature in the dark. 4 volumes of water were added, and the reaction was dried as before. Cleavage products were resuspended in 0.1% trifluoroacetic acid. Peptide separation and automated Edman degradation were performed at the UIUC Protein Sciences Facility.
RESULTS
Electrophoretic mobility of a B. subtilis chemoreceptor is dependent on the cheD gene product-Previous work to characterize several B. subtilis chemoreceptors demonstrated that the mcpB gene product fractionated near its expected M r (71,800) during SDS-PAGE (14) . Despite being encoded with a nearly identical M r as McpB, the mcpA gene product (M r -72,400) fractionated as several distinct bands at a significantly higher apparent M r (ϳ95,000). Recently, however, immunoblot analysis revealed the unexpected absence of McpA-specific crossreacting material in the lysate of a cheD mutant (21) . In an attempt to elucidate the biochemical role of the cheD gene product, we investigated the apparent absence of McpA.
One possibility to explain the absence of McpA is that the synthesis or stability of McpA is impaired in the cheD mutant. We found this possibility unlikely since two other B. subtilis receptors (McpB and McpC) were detected at wild-type levels in the cheD lysate (21) . However, the antibody used for detection of McpA also cross-reacts with McpB (21); therefore, if McpA and McpB co-fractionated, they would be indistinguishable. We hypothesized that the cheD mutation affected the electrophoretic mobility of McpA such that it co-fractionated with McpB. To test this hypothesis, we expressed a single receptor gene (mcpA or mcpB) in two backgrounds containing mutations in the 10 known receptor genes (⌬10mcp); one was che ϩ , and the other was a cheD mutant derivative. We assessed the electrophoretic mobility of each receptor during SDS-PAGE (Fig. 1) . McpB exhibited no mobility changes due to the cheD mutation under these conditions (not shown, but see below). In contrast, McpA displayed a substantial difference in mobility due to the cheD mutation (Fig. 1, compare lanes 1 and 2) . The cheD mutation resulted in an McpA protein that did not fractionate as several bands at the previously described relatively high apparent M r ; instead, it fractionated as a single band closer to its expected M r . Thus, CheD is required for an elec- 
CheD-dependent Electrophoretic Mobility Shift of McpA Is Independent of Known Receptor Modification
Enzymes-Chemoreceptors of E. coli are known to undergo electrophoretic mobility shifts due to changes in the extent of their modification (methylation, demethylation, or deamidation) catalyzed by the CheR methyltransferase and the CheB methylesterase (17, 18) . To test the possibility that CheD-dependent mobility shifts of McpA were due to analogous changes in the level of its modification catalyzed by the B. subtilis methyltransferase or methylesterase, we expressed mcpA in ⌬10mcp strains harboring cheR (methyltransferase) or cheR cheB (methyltransferase and methylesterase) mutations. Immunoblot analysis of McpA reveals that the mobility shift to a higher apparent M r occurs normally in both backgrounds and is dependent on CheD (Fig.  1, compare lanes 3-5) . Thus, neither of the two enzymes shown previously to modify bacterial chemoreceptors is required for the CheD-dependent mobility shift of McpA to a higher apparent M r , implying that CheD is itself involved in chemoreceptor modification.
Although neither of the two previously known chemoreceptor modification enzymes is required for the CheD-dependent mobility shift of McpA, it is apparent from Fig. 1 2 and 4) . This effect of methylation on chemoreceptor mobility has been well documented for chemoreceptors of E. coli (17, 18) and is consistent with the observation of Hanlon and Ordal (14) that the mcpA gene product accounts for several distinct methylated bands in extracts of wild-type B. subtilis.
Deamidation of McpA Is Necessary and Sufficient to Account for the CheD-dependent Mobility Shift-In contrast to the effect of methylation on chemoreceptor mobility, E. coli receptors that are deamidated migrate more slowly through acrylamide gels (19, 20) . The DNA-encoded amino acid sequence of B. subtilis McpA contains five predicted methylation sites, one of which is encoded as a Gln (Gln-594) (11) . Therefore, by analogy to the E. coli receptors, deamidation of this site on McpA would be expected to produce a mobility shift. Although no methylesterase-dependent mobility shifts could be observed for McpA (Fig. 1, compare lanes 3 and 5) , the CheD-dependent mobility shift of McpA mimics the effect of deamidation. In light of this observation, we hypothesized that the CheD-dependent modification of McpA was deamidation of Gln-593, Gln-594, or both.
To test this hypothesis, we constructed mutant alleles of mcpA in which we substituted the pair of wild-type Gln codons at positions 593 and 594 with Glu codons (to mimic deamidation) or Ala codons (to prevent deamidation). Substitution of Gln by Glu at these sites should produce receptors that are synthesized in their CheD-processed form and therefore fractionate at the CheD-modified position (high relative M r ) even in the absence of modification by CheD. Conversely, substitution of Gln by Ala should produce receptors that are unable to be processed and therefore unable to fractionate at the CheDmodified position even in the presence of CheD. Consequently, the Ala-substituted receptors would be expected to always fractionate at the unmodified position (low relative M r ). Because we had shown that the cheR methyltransferase was not required for CheD modification to take place (Fig. 1) , we compared fractionation of the site-directed McpA mutant proteins in the ⌬10mcp cheR and ⌬10mcp cheR cheD genetic backgrounds. The cheR mutation simplified interpretation of the data inasmuch as the wild-type McpA derived from this background fractionated in a CheD-dependent manner at one of only two locations: (i) unmodified (low relative M r ) or (ii) unmethylated but CheD-modified (high relative M r ). In contrast, the presence of the methyltransferase resulted in a variety of methylated forms that obscured the effect of CheD modification (Fig. 1, lane 1) .
Immunoblot analysis of the McpA mutants is presented in Fig. 2 Glu amino acid substitutions in the CheD-modified form of McpA; therefore, as an additional test, we determined the protein sequence at residues 593 and 594 of unmodified McpA and compared it with that of CheD-modified McpA. This analysis was facilitated by the presence of Met-588 just upstream of the target region (Fig. 3B) because CNBr cleavage liberates a peptide suitable for Edman degradation in the region of interest. To obtain protein for analysis, we expressed a His 6 -tagged cytoplasmic fragment of McpA (c-fragment) in an E. coli strain deleted for all chemotaxis genes (RP3098); immunoblot analysis demonstrated that it fractionated during SDS-PAGE as a single band when derived from this host (Fig. 3A, lane 1) . When co-expressed with B. subtilis CheD, the c-fragment was subject to a mobility shift analogous to that of full-length McpA (Fig.  3A, lane 2) . Thus, the isolated McpA cytoplasmic fragment is able to serve as a substrate for CheD modification in a heterologous host bacterium. We independently purified both forms of the c-fragment (unmodified and CheD-modified) from RP3098 and cleaved them with CNBr. The peptides were fractionated via high pressure liquid chromatography, and the target peptide from each C-fragment was sequenced by automated Edman degradation. The protein sequence obtained from this analysis is shown in Fig. 3B along with the DNAencoded amino acid sequence in the region. The amino acid sequence determined for the unmodified c-fragment corresponds exactly to the DNA-encoded McpA sequence, indicating that CNBr treatment had no adverse effects on the Gln residues in this peptide. The amino acid sequence determined for the CheD-modified c-fragment unequivocally demonstrates that CheD modification of McpA results in deamidation of Gln-593 and Gln-594.
Deamidation Is Catalyzed by CheD-CheD-dependent deamidation of McpA occurs in a heterologous host whose genome contains no cheD homolog (Fig. 3) , suggesting that the CheD protein itself possesses amidase activity. To test this hypothesis, we purified a recombinant fusion protein in which CheD was fused to the C terminus of glutathione S-transferase. We incubated this fusion protein in vitro with the purified c-fragment and analyzed the reactions via immunoblotting (Fig. 4) . The results show that GST-CheD specifically produced an electrophoretic mobility shift of the unmodified c-fragment (lanes  3-8) , generating a c-fragment form whose mobility corresponds to that of the purified, CheD-modified c-fragment (top band). No mobility change was observed when buffer alone was added to the c-fragment (lane 1) nor when GST-CheD was added to the purified, CheD-modified c-fragment (not shown). Based on these results, we conclude that the CheD protein enzymatically deamidates McpA. As a control to ensure that the GST component of the fusion exhibited no activity toward the c-fragment, GST was co-expressed with the c-fragment in strain RP3098. Co-expression of GST resulted in no mobility shifts for the c-fragment, indicating that GST itself was not able to act on the receptor (not shown).
CheD Modifies Other Receptors-In previous work, a B. subtilis cheD mutant exhibited impaired taxis toward all attractants tested, including attractants known to be sensed exclusively via receptors other than McpA (24) . These attractants included asparagine, an McpB-mediated effector, and proline, an McpC-mediated effector (14) . Because CheD is required for effective taxis mediated by McpB and McpC, we hypothesized that these receptors are also deamidated by CheD. To test for CheD modification, we expressed either mcpB or mcpC in ⌬10mcp cheR and ⌬10mcp cheR cheD genetic backgrounds and analyzed the receptor fractionation pattern. However, using our standard electrophoretic conditions (10-cm gel), we could not observe a CheD-dependent mobility shift for either of these receptors (not shown). To test the possibility that electrophoresis may have been performed at insufficient resolution to distinguish between the unmodified and CheD-modified receptor forms, we repeated the analysis, using a 25-cm gel, and extended the electrophoresis time by 5-fold. Under these conditions, CheD-dependent mobility shifts could be observed for both McpB and McpC (Fig. 5, lanes 1 versus 2 for McpB; lanes 3 versus 4 for McpC), suggesting that these receptors are also deamidated by CheD. DISCUSSION We have established a function for the CheD protein of bacterial chemotaxis. First, we identified a CheD-dependent electrophoretic mobility shift for the B. subtilis chemoreceptor McpA (Fig. 1) . Then, we demonstrated that deamidation of McpA was necessary and sufficient to account for a mobility shift to a higher apparent M r (Fig. 2) and subsequently, that CheD-modified McpA was deamidated at residues Gln-593 and Gln-594 (Fig. 3) . Finally, we showed that a purified CheD fusion is capable of generating an identical McpA mobility shift in vitro (Fig. 4) . Therefore, we conclude that B. subtilis CheD functions as a glutaminase, catalyzing amide hydrolysis of McpA Gln-593 and Gln-594 to yield an McpA protein that migrates more slowly through acrylamide gels.
In the chemotaxis system of E. coli, receptor deamidation has long been known to be performed by the CheB methylesterase (15) . Consequently, it was thought previously that the B. subtilis CheB methylesterase possessed such an activity. Our results show that it is no longer necessary to attribute such a function to B. subtilis CheB as deamidation can be accomplished by CheD. Furthermore, the observation that the presence of CheB (without CheD) does not result in the higher apparent M r (deamidated) form of McpA (Fig. 1, lanes 2 and 4) suggests that B. subtilis CheB may not be capable of catalyzing deamidation; CheB may therefore be dedicated exclusively to demethylation. The widespread phylogenetic distribution of CheD homologs suggests that use of independent proteins to catalyze demethylation versus deamidation is a receptor modification strategy employed by most chemotactic bacteria and archaea. At present, the advantage of utilizing such a strategy is not obvious. We speculate that it may allow an additional degree of temporal regulation not possible with a single enzyme or, alternatively, that it may allow the use of additional modification sites initially not accessible to CheB alone, such as the putative second site of CheD-dependent modification on McpA (see below).
If, however, B. subtilis CheB does not catalyze receptor deamidation, how can we rationalize the results of Kirsch et al. (16) indicating that B. subtilis CheB can complement a cheB mutant of E. coli in a soft agar swarm assay? It is well known that mutants that are either predominantly tumbly or predominantly smooth-swimming (extreme clockwise or counterclockwise flagellar rotational biases, respectively) spread very poorly during swarm assays (34) . The spreading of such mutants in swarm agar can be significantly enhanced by adjustment of the flagellar rotational bias to a more intermediate level (producing a mutant with more balanced levels of swimming and tumbling) (34 -36) . Therefore, one possibility to explain the cheB complementation result might be simply that sufficient methylesterase activity of the B. subtilis enzyme on the E. coli receptors exists to mitigate the predominantly tumbly signaling state (which exists presumably as a consequence of the fully methylated receptors) normally found in cheB mutants (37, 38) . Reducing the extreme flagellar rotational bias would allow for more effective swarm expansion in the absence of receptor deamidation. Alternatively, it might be possible that B. subtilis CheB is, in fact, capable of deamidation at consensus methylation sites that contain a Glu-Gln pair (such as those on E. coli receptors) but not at modification sites that contain a Gln-Gln pair (such as Gln-593/Gln-594 of B. subtilis McpA). Thus, in this scenario, B. subtilis CheB would be fully capable of substituting for all activities of its E. coli counterpart during the complementation experiment. According to this scheme, CheD would be specifically required to deamidate GlnGln pairs on B. subtilis receptors. (Fig. 2) . We propose that the production of these forms reflects the presence of a second, unidentified site of CheD modification on McpA. The fractionation patterns observed in Fig. 2 , producing a partially modified form that exhibits a partial mobility shift.
The existence of a second site of CheD modification is supported by the results of in vitro modification of the c-fragment where an intermediate form of the c-fragment can be observed under conditions in which the reaction is not complete (Fig. 4) . Furthermore, this intermediate form of the c-fragment was observed in vivo when the c-fragment was expressed in B. subtilis (not shown). We note that, unlike Gln-593/Gln-594, the second site of CheD modification must occur at a position on McpA, that does not satisfy the conserved methylation consensus sequence because all putative sites of methylation on McpA, other than Gln-594, are encoded as Glu-Glu pairs (11) . Consequently, additional sites of CheD modification cannot yet be predicted on the basis of sequence alone.
Physiological Role of CheD Deamidation-Deamidation of E. coli receptors is known to influence the kinase-activating ability of the receptors (39) . In the E. coli system, deamidation (and demethylation) produces receptors that inhibit kinase activity, resulting in suppression of phosphotransfer to the CheY response regulator. In contrast, deamidation of B. subtilis receptors by CheD appears to promote kinase activity. Kinase activity produces CheY-P, which, in B. subtilis, results in counterclockwise flagellar rotation. Because the prestimulus flagellar rotational bias of cheD cells is very low (clockwise) (21, 24) , it appears that receptor deamidation is required for basal kinase activity.
However, the role of CheD-mediated deamidation seems to extend beyond that of promoting basal kinase activity insofar as it also appears to be required for ligand-induced kinase activation. For example, tethered-cell analysis of the cheD mutant revealed that only about 50% of the cells examined responded behaviorally to asparagine stimulation; none of the cells examined responded to proline stimulation (21) . Therefore, CheD deamidation of McpB and McpC appears to affect the sensitivity of B. subtilis cells to chemoeffectors recognized by these receptors. Unfortunately, we have not been able to assess the functional requirement for CheD-mediated deamidation of McpA during signal transduction because a cognate ligand for McpA has not yet been identified. However, based on the phenotypes of the cheD mutant, we propose that CheDmediated deamidation is required for productive communication of all conformational signals generated by the receptors to the CheA kinase.
We imagine several possible mechanisms to account for these observations. (i) Unprocessed receptors cannot participate in assembly of a properly formed ternary complex with the coupling proteins and/or CheA kinase; therefore, these receptors can neither stimulate basal kinase activity nor communicate an environmental signal to the kinase. (ii) Unprocessed receptors can form ternary complexes, but these complexes exist in a conformation that strongly inhibits the kinase irrespective of the ligand occupancy state of the receptor. (iii) Unprocessed receptors cannot efficiently form higher order arrays, thought to be necessary for receptors to function as an ensemble to regulate the associated CheA kinase pool (40) .
These possibilities are not necessarily mutually exclusive. For example, perturbations in ternary complex formation will likely affect receptor interactions required for ensemble formation and function. A formal alternative to the above possibilities is that the CheD protein itself (rather than its enzymatic activity) may play a structural role in formation or maintenance of receptor/kinase complexes. However, at this time, we have no direct evidence to support such a role. Additional work is required to understand the role of CheD-mediated receptor deamidation during chemotactic sensory transduction.
